This trial is investigating whether it is better to continue taking a low dose of buprenorphine or to discontinue it entirely before surgery, in order to manage postoperative pain without interrupting treatment for opioid use disorder.
3 Primary · 6 Secondary · Reporting Duration: 48 hours after surgery
80 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 4
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: